BRIDGE BIOTHERAPEUTICS INTEGRATES CDD VAULT INTO ITS R&D PLATFORM TO HARMONIZE RESEARCH AND DRUG DISCOVERY PROJECT MANAGEMENT

Bridge has been enhancing its research and drug discovery engines by efficiently managing scientific assets on a collaborative database solution CDD provides a secure research database platform enabling seamless collaboration between drug discovery and development teams that are in different parts of the world Seongnam-si and San Francisco —  Bridge Biotherapeutics, Inc., a publicly-traded biotech [...]

Ampersand Completes Sale of Portfolio Company Nexcelom Bioscience to PerkinElmer

WELLESLEY, Mass. -- Ampersand Capital Partners announced today that it has completed the sale of Nexcelom Bioscience, one of its portfolio companies and a leading provider of automated cell counting solutions, to PerkinElmer for $260 million in cash. Founded in 2003 and headquartered in Lawrence, Massachusetts, Nexcelom is the manufacturer of innovative Cellometer, Cellaca MX, and Celigo image cytometry [...]

Park Systems Announces Park FX40, the Autonomous AFM with Built-in Intelligence – A Groundbreaking New Class of Atomic Force Microscope

Park Systems, the fastest growing manufacturer of Atomic Force Microscopes (AFM) just announced Park FX40, a groundbreaking autonomous atomic force microscope, infused with innovative robotics, intelligent learning features, safety mechanisms, AI based software and specialized add-ons. Park FX40 Atomic Force Microscope is the first AFM to autonomously execute all up-front set up and scanning processes, [...]

Quantum-Si Signs Lease for Product Development and Operations Facility in San Diego Biotechnology Hub

GUILFORD, Conn. -- Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, announced today that it has entered into a lease agreement with Phase 3 Real Estate Partners, Inc. to develop a 25,586-square-foot product development and operations facility in San Diego, CA. The new facility, located in Sorrento Mesa, is being designed to scale production [...]

BIO-TECHNE AND CATAMARAN BIO ANNOUNCE EXPANDED COLLABORATION FOR CAR-NK CELL MANUFACTURING TECHNOLOGIES

Broadened agreement includes the development of novel technologies for allogeneic CAR-NK cell expansion Catamaran also secures broad worldwide license to TcBuster™ transposon system for clinical and commercial manufacturing of next generation cell therapies MINNEAPOLIS, MN and CAMBRIDGE, MA – Bio-Techne Corporation (NASDAQ: TECH) and Catamaran Bio today announced an expansion of their collaboration for the [...]

The Launch of U-Load Dextramer® with Peptide Receptive MHC I and MHC II Monomers Greatly Expands Flexibility while Ensuring Reliable Sensitivity in Exploring Diversity of Cellular Immune Responses

Virum, Denmark – Life Science Newswire – Immudex announces the launch of the new U-Load Dextramer® product line that allows scientists to swiftly assemble their own sensitive antigen-specific Dextramer® reagents for immune monitoring directly in the lab using loadable MHC class I easYmer® and the novel loadable MHC class II monomers, U-Load MHC II. Whether via flow cytometry [...]

Eppendorf Award for Young European Investigators 2021 goes to Tanmay Bharat, United Kingdom

Virtual award ceremony due to the ongoing COVID-19 pandemic on 24.06.2021 as Livestream Hamburg -- In 2021, Eppendorf AG, the Hamburg life sciences company, is presenting its highly prestigious research prize for the 26th time. The independent Eppendorf Award Jury chaired by Prof. Reinhard Jahn announced Dr. Tanmay Bharat, Sir William Dunn School of Pathology, [...]

BioTools and Liverpool ChiroChem announce a collaboration aimed at accelerating the discovery of novel, stereo-defined, enantioenriched compounds.

Florida, USA –  BioTools, provider of instrumentation and analytical services for structure elucidation of biologics and chiral molecules for drug discovery, and Liverpool ChiroChem (LCC), a chemical technology innovator that produces thousands of novel, multifunctional 3D fragments/scaffolds/building blocks to support new chiral entities (NCE) discovery & development, announce a collaboration to determine the absolute configuration [...]

Waters Corporation Appoints Wei Jiang to Board of Directors

MILFORD, Mass. -- Waters Corporation (NYSE: WAT) today announced the appointment of Wei Jiang to its Board of Directors, effective July 14, 2021. Mr. Jiang currently serves as Executive Vice President and President, Bayer Pharmaceuticals Region China & APAC and President, Bayer Group Greater China. Dr. Flemming Ornskov, Chairman of the Board, said, “We are excited [...]

Cellexus receive Innovate UK grant

We are delighted to have been awarded a grant of up to £320,000 from Innovate UK, the UK’s innovation agency, for the research and development of a 100L bioreactor for stem cell applications. Our existing range Our existing range of patented airlift, single-use bioreactors includes the CellMaker Systems: Regular, Low Flow and Plus – created [...]

Access IBO on Knowledge Center